AgroSpheres, Inc.

AgroSpheres, Inc. is a US-based company specializing in bio-based agricultural solutions that enhance crop health and provide pest and disease protection through innovative technologies. Founded in 2016 and headquartered in Charlottesville, US, AgroSpheres, Inc. focuses on developing agricultural biotechnology solutions.

The company has successfully completed 10 deals, with its most recent funding round being a Series B round on July 30, 2024, raising USD 9. 065 mn. The founders, Ameer Shakeel and Payam Pourtaheri, have a history of innovation in agricultural sciences and are committed to sustainable farming practices. The latest funding round was led by Zebra Impact and Mirabaud Asset Management, with participation from other notable investors such as Lewis & Clark Ventures, Ospraie Management, FMC Corporation, Bidra Innovation Ventures, and Cavallo Ventures.

AgroSpheres specializes in bio-based agricultural solutions designed to enhance crop health and protect against pests and diseases. Their core products include a unique biodegradable encapsulation technology that utilizes RNA interference (RNAi) to selectively target and deactivate specific genes in pests, reducing crop damage. Additionally, they offer plant extracts that promote plant vitality and disease prevention, with a streamlined one-step fermentation process providing stability and a customizable release profile. AgroSpheres primarily serves agricultural markets in North America and is expanding its reach to regions focused on sustainable farming practices.

AgroSpheres generates revenue through direct sales of its flagship bioinsecticide products, marketed to agricultural producers and distributors. The company operates a B2B model, partnering with agricultural firms and wholesalers who distribute its products to farmers seeking eco-friendly pest management solutions. Revenue is supported by a recent Series B funding round of USD 9. 065 mn, reflecting strong investor confidence and facilitating further development and commercialization of their offerings, ultimately enhancing AgroSpheres' growth trajectory in the agricultural biotechnology sector.

In July 2024, AgroSpheres, Inc. raised USD 9. 065 mn in Series B funding to advance product development, build biomanufacturing facilities, and expand into new markets. The company plans to utilize this funding to further develop its AgriCell platform and introduce new products focused on sustainable agricultural practices.

Specific targets for market expansion include regions within North America and other areas prioritizing eco-friendly farming solutions. The funding will enhance production capabilities and support these growth initiatives.